$8.84
0.020.23%
al cierre: -
$8.80
-0.04-0.45%
After hour: Aug 15, 6:45 PM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Emergent BioSolutions informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
nov 5
Estimación de BPA
$0.240
Estimación de ingresos trimestrales
$225.00M
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$812.50M
Analice el historial de beneficios de Emergent BioSolutions utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
EBS | Emergent BioSolutions | $1.37 | $0.24 | — | — | $293.80M | $225.00M | — | — | 11/05/2025 | |
EBS | Emergent BioSolutions | -$2.32 | -$0.72 | $0.16 | 140.00% | $254.70M | $105.00M | $140.90M | — | 08/06/2025 | |
EBS | Emergent BioSolutions | $0.59 | $0.44 | $0.71 | 61.36% | $300.40M | $219.00M | $222.20M | — | 05/07/2025 | |
EBS | Emergent BioSolutions | -$0.77 | -$0.49 | $0.05 | 110.00% | $276.60M | $254.67M | $194.70M | -23.55% | 03/03/2025 | |
EBS | Emergent BioSolutions | -$1.09 | $0.14 | $1.37 | 878.57% | $270.50M | $297.50M | $293.80M | -1.24% | 11/06/2024 | |
EBS | Emergent BioSolutions | -$1.06 | -$0.94 | -$2.32 | -146.81% | $337.90M | $190.00M | $254.70M | 34.05% | 08/06/2024 | |
EBS | Emergent BioSolutions | -$3.26 | -$0.83 | $0.59 | 171.08% | $164.30M | $224.50M | $300.40M | 33.81% | 05/01/2024 | |
EBS | Emergent BioSolutions | -$0.31 | -$0.19 | -$0.77 | -305.26% | $330.70M | $293.53M | $276.60M | -5.77% | 03/06/2024 | |
EBS | Emergent BioSolutions | -$1.27 | -$0.22 | -$0.87 | -295.45% | $240.00M | $237.43M | $270.50M | 13.93% | 11/08/2023 | |
EBS | Emergent BioSolutions | -$0.86 | -$0.47 | -$1.06 | -125.53% | $242.70M | $217.03M | $337.90M | 55.69% | 08/08/2023 | |
EBS | Emergent BioSolutions | $0.18 | -$1.24 | -$3.17 | -155.65% | $307.50M | $143.28M | $165.10M | 15.23% | 05/09/2023 | |
EBS | Emergent BioSolutions | $4.50 | $0.04 | -$0.31 | -875.00% | $723.20M | $296.62M | $330.70M | 11.49% | 02/27/2023 | |
EBS | Emergent BioSolutions | -$0.36 | -$0.06 | -$1.27 | -2016.67% | $329.00M | $268.30M | $240.00M | -10.55% | 11/08/2022 | |
EBS | Emergent BioSolutions | $0.33 | $0.37 | -$0.86 | -332.43% | $397.50M | $270.94M | $242.70M | -10.42% | 08/01/2022 | |
EBS | Emergent BioSolutions | $1.53 | -$0.64 | $0.18 | 50.00% | $343.00M | $259.00M | $307.50M | 8.66% | 04/28/2022 | |
EBS | Emergent BioSolutions | $3.67 | $4.27 | $4.50 | 5.39% | $583.00M | $691.36M | $723.20M | 4.61% | 02/24/2022 | |
EBS | Emergent BioSolutions | $2.19 | $2.35 | -$0.36 | -115.32% | $385.20M | $486.84M | $329.00M | -32.42% | 11/04/2021 | |
EBS | Emergent BioSolutions | $1.98 | $1.54 | $0.33 | -78.57% | $394.70M | $398.93M | $397.50M | -0.36% | 07/29/2021 | |
EBS | Emergent BioSolutions | $0.01 | $1.12 | $1.53 | 36.61% | $192.50M | $358.47M | $343.00M | -4.32% | 04/29/2021 | |
EBS | Emergent BioSolutions | $1.57 | $3.19 | $3.67 | 15.05% | $360.40M | $563.60M | $583.00M | 3.44% | 02/18/2021 | |
EBS | Emergent BioSolutions | $1.21 | $2.12 | $2.19 | 3.30% | $311.80M | $437.93M | $385.20M | -12.04% | 11/05/2020 |
Emergent BioSolutions (EBS) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-06 | $0.16 | $-0.72 | 140.0 % |
| Q1 | 2025-05-07 | $0.71 | $0.44 | 61.4 % |
| Q4 | 2025-03-03 | $0.05 | $-0.49 | 110.0 % |
| Q3 | 2024-11-06 | $1.37 | $0.14 | 878.6 % |
Emergent BioSolutions (EBS) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q4 | 2025-03-03 | $194.70M | $254.67M | -23.5 % |
| Q3 | 2024-11-06 | $293.80M | $297.50M | -1.24 % |
| Q2 | 2024-08-06 | $254.70M | $190.00M | 34.1 % |
| Q1 | 2024-05-01 | $300.40M | $224.50M | 33.8 % |
PREGUNTAS FRECUENTES
¿Cuándo Emergent BioSolutions (NYSE:EBS) publicará los resultados?
Está previsto que Emergent BioSolutions (EBS) presente resultados el noviembre 5, 2025. Los últimos resultados se publicaron el agosto 6, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Emergent BioSolutions (NYSE:EBS)?
El BPA real fue de $0.16, que superó la estimación de $-0.72.
¿Cuáles fueron los ingresos de Emergent BioSolutions (NYSE:EBS)?
Los ingresos reales fueron $140.9M, que superó la estimación de $105M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.